Urology Times Newsletter

VOICES IN UROLOGY

Urology APPs: Making an impact during the COVID-19 pandemic

"Urology APPs are making an impact during this COVID-19 pandemic. Those deployed are using their individualized skillsets to care for patients," writes Adele M. Caruso, DNP, CRNP.

Read her blog post

Could mpMRI replace prostate Bx for surveillance protocols?

"Even in this selected cohort of men with very low-risk features, stable MRI score was not protective against disease progression during surveillance," writes Badar M. Mian, MD.

Learn more

An end to the decline in prostate cancer mortality

"The recently reported change in PCa death rates should prompt men to undergo genetic testing and have a discussion with their doctor regarding the benefits and potential harms of PSA-based screening based on their individualized risk of developing the disease," write Franklin Gaylis, MD, and A. Karim Kader, MD, PhD.

Read their op-ed

SURVEY

Is DRE still a relevant tool in the management of prostate cancer?

Real-world data on the prostate cancer “revolution”

This Partner Perspective examines and reviews key insights from the PROCEED registry, a multicenter, open-label, observational registry of nearly 2,000 men with mCRPC.

Read now.